Son Bao Nguyen, Thomas Bastholm Olesen, Sidsel Louise Domazet, Sofie Frigaard Kristoffersen, Jens Steen Nielsen, Michael Hecht Olsen, Jacob Volmer Stidsen
{"title":"中度至剧烈体育活动对新近诊断为2型糖尿病的丹麦成人全身血管阻力的影响:一项横断面研究","authors":"Son Bao Nguyen, Thomas Bastholm Olesen, Sidsel Louise Domazet, Sofie Frigaard Kristoffersen, Jens Steen Nielsen, Michael Hecht Olsen, Jacob Volmer Stidsen","doi":"10.1038/s41371-025-01049-x","DOIUrl":null,"url":null,"abstract":"Strenuous physical activity alleviates the risk of elevated blood pressure (BP) presumably through a reduction in systemic vascular resistance (SVR). Using logistic multivariate regression models, we investigated whether moderate to vigorous physical activity (MVPA) was negatively associated with high SVR among adults with Type 2 Diabetes (T2DM). Additionally, we assessed associations between other cardiometabolic risk factors and SVR. SVR was assessed using thoracic electrical bioimpedance; high SVR was defined as ≥20% above normal. Time spent on MVPA was calculated using accelerometer data and age-specific cut points. In fasting blood samples, we measured plasma glucose and c-peptide and used the Homeostasis Model Assessment 2-Insulin Resistance (HOMA2-IR) to estimate Insulin resistance. Results are adjusted for age, sex, BP, body mass index (BMI), HOMA2-IR, medication, and smoking. We included 824 adults (mean age = 61.6 years) with recently diagnosed T2DM (interquartile range for diabetes duration = 4.9 years). 41% were females. Median MVPA was 10.7 min/day, and 50.5% had high SVR. Increments of 14.4 min/day in MVPA were independently associated with a lower risk of high SVR (OR = 0.69, [0.57;0.83]). Other risk determinants of high SVR were female sex (OR = 2.06, [1.49;2.86]), each increase in BMI of 6.16 kg/m2 (OR = 2.20, [1.76;2.73]), and HOMA2-IR of 1.79 (OR = 2.33, [1.09;4.96]). BMI had a notably greater impact on explained variability of SVR than MVPA when comparing the coefficient of determination (pseudo-R2, 35.0% vs. 7.9%). Although increased levels of MVPA are associated with a reduced risk of high SVR, BMI appears to have a more pronounced effect on SVR.","PeriodicalId":16070,"journal":{"name":"Journal of Human Hypertension","volume":"39 10","pages":"701-708"},"PeriodicalIF":3.4000,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of moderate to vigorous physical activity on systemic vascular resistance in Danish adults with recently diagnosed type 2 diabetes: a cross-sectional study\",\"authors\":\"Son Bao Nguyen, Thomas Bastholm Olesen, Sidsel Louise Domazet, Sofie Frigaard Kristoffersen, Jens Steen Nielsen, Michael Hecht Olsen, Jacob Volmer Stidsen\",\"doi\":\"10.1038/s41371-025-01049-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Strenuous physical activity alleviates the risk of elevated blood pressure (BP) presumably through a reduction in systemic vascular resistance (SVR). Using logistic multivariate regression models, we investigated whether moderate to vigorous physical activity (MVPA) was negatively associated with high SVR among adults with Type 2 Diabetes (T2DM). Additionally, we assessed associations between other cardiometabolic risk factors and SVR. SVR was assessed using thoracic electrical bioimpedance; high SVR was defined as ≥20% above normal. Time spent on MVPA was calculated using accelerometer data and age-specific cut points. In fasting blood samples, we measured plasma glucose and c-peptide and used the Homeostasis Model Assessment 2-Insulin Resistance (HOMA2-IR) to estimate Insulin resistance. Results are adjusted for age, sex, BP, body mass index (BMI), HOMA2-IR, medication, and smoking. We included 824 adults (mean age = 61.6 years) with recently diagnosed T2DM (interquartile range for diabetes duration = 4.9 years). 41% were females. Median MVPA was 10.7 min/day, and 50.5% had high SVR. Increments of 14.4 min/day in MVPA were independently associated with a lower risk of high SVR (OR = 0.69, [0.57;0.83]). Other risk determinants of high SVR were female sex (OR = 2.06, [1.49;2.86]), each increase in BMI of 6.16 kg/m2 (OR = 2.20, [1.76;2.73]), and HOMA2-IR of 1.79 (OR = 2.33, [1.09;4.96]). BMI had a notably greater impact on explained variability of SVR than MVPA when comparing the coefficient of determination (pseudo-R2, 35.0% vs. 7.9%). Although increased levels of MVPA are associated with a reduced risk of high SVR, BMI appears to have a more pronounced effect on SVR.\",\"PeriodicalId\":16070,\"journal\":{\"name\":\"Journal of Human Hypertension\",\"volume\":\"39 10\",\"pages\":\"701-708\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Human Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/s41371-025-01049-x\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Human Hypertension","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41371-025-01049-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
Impact of moderate to vigorous physical activity on systemic vascular resistance in Danish adults with recently diagnosed type 2 diabetes: a cross-sectional study
Strenuous physical activity alleviates the risk of elevated blood pressure (BP) presumably through a reduction in systemic vascular resistance (SVR). Using logistic multivariate regression models, we investigated whether moderate to vigorous physical activity (MVPA) was negatively associated with high SVR among adults with Type 2 Diabetes (T2DM). Additionally, we assessed associations between other cardiometabolic risk factors and SVR. SVR was assessed using thoracic electrical bioimpedance; high SVR was defined as ≥20% above normal. Time spent on MVPA was calculated using accelerometer data and age-specific cut points. In fasting blood samples, we measured plasma glucose and c-peptide and used the Homeostasis Model Assessment 2-Insulin Resistance (HOMA2-IR) to estimate Insulin resistance. Results are adjusted for age, sex, BP, body mass index (BMI), HOMA2-IR, medication, and smoking. We included 824 adults (mean age = 61.6 years) with recently diagnosed T2DM (interquartile range for diabetes duration = 4.9 years). 41% were females. Median MVPA was 10.7 min/day, and 50.5% had high SVR. Increments of 14.4 min/day in MVPA were independently associated with a lower risk of high SVR (OR = 0.69, [0.57;0.83]). Other risk determinants of high SVR were female sex (OR = 2.06, [1.49;2.86]), each increase in BMI of 6.16 kg/m2 (OR = 2.20, [1.76;2.73]), and HOMA2-IR of 1.79 (OR = 2.33, [1.09;4.96]). BMI had a notably greater impact on explained variability of SVR than MVPA when comparing the coefficient of determination (pseudo-R2, 35.0% vs. 7.9%). Although increased levels of MVPA are associated with a reduced risk of high SVR, BMI appears to have a more pronounced effect on SVR.
期刊介绍:
Journal of Human Hypertension is published monthly and is of interest to health care professionals who deal with hypertension (specialists, internists, primary care physicians) and public health workers. We believe that our patients benefit from robust scientific data that are based on well conducted clinical trials. We also believe that basic sciences are the foundations on which we build our knowledge of clinical conditions and their management. Towards this end, although we are primarily a clinical based journal, we also welcome suitable basic sciences studies that promote our understanding of human hypertension.
The journal aims to perform the dual role of increasing knowledge in the field of high blood pressure as well as improving the standard of care of patients. The editors will consider for publication all suitable papers dealing directly or indirectly with clinical aspects of hypertension, including but not limited to epidemiology, pathophysiology, therapeutics and basic sciences involving human subjects or tissues. We also consider papers from all specialties such as ophthalmology, cardiology, nephrology, obstetrics and stroke medicine that deal with the various aspects of hypertension and its complications.